Asset Management One Co. Ltd. Has $97.65 Million Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Asset Management One Co. Ltd. boosted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.2% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 182,559 shares of the medical equipment provider’s stock after buying an additional 2,106 shares during the quarter. Asset Management One Co. Ltd. owned approximately 0.05% of Intuitive Surgical worth $97,647,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of ISRG. Berbice Capital Management LLC acquired a new stake in shares of Intuitive Surgical in the 4th quarter valued at approximately $26,000. Godsey & Gibb Inc. lifted its stake in Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. acquired a new stake in Intuitive Surgical in the third quarter valued at approximately $33,000. Decker Retirement Planning Inc. acquired a new position in shares of Intuitive Surgical during the fourth quarter worth $36,000. Finally, Capital Performance Advisors LLP bought a new position in shares of Intuitive Surgical in the 3rd quarter valued at $38,000. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Up 0.3 %

NASDAQ:ISRG opened at $591.39 on Friday. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The stock has a market capitalization of $210.64 billion, a price-to-earnings ratio of 92.26, a PEG ratio of 5.67 and a beta of 1.39. The firm has a fifty day simple moving average of $557.70 and a two-hundred day simple moving average of $517.49.

Insider Transactions at Intuitive Surgical

In other Intuitive Surgical news, EVP Robert Desantis sold 376 shares of the stock in a transaction that occurred on Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,967,734. This represents a 6.39 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Myriam Curet sold 408 shares of the firm’s stock in a transaction that occurred on Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total value of $240,618.00. Following the completion of the sale, the executive vice president now directly owns 353 shares of the company’s stock, valued at $208,181.75. This trade represents a 53.61 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 6,348 shares of company stock valued at $3,587,582 in the last 90 days. 0.90% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of equities analysts have issued reports on the company. The Goldman Sachs Group set a $604.00 target price on Intuitive Surgical in a report on Friday, October 18th. Stifel Nicolaus upped their price objective on Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research note on Thursday, December 5th. CICC Research began coverage on shares of Intuitive Surgical in a research report on Monday, January 27th. They set a “neutral” rating and a $550.00 target price on the stock. Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and upped their price target for the company from $522.00 to $650.00 in a research report on Monday, December 2nd. Finally, Barclays lifted their price target on shares of Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have given a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.